10 20 30 40 50 60 70 80 2GVQ - Header ----|----|----|----|----|----|----|----|----|----|----|----|----|----|----|----| Asymmetric UnitHEADER TRANSFERASE 03-MAY-06 2GVQ
TITLE ANTHRANILATE PHOSPHORIBOSYL-TRANSFERASE (TRPD) FROM S. TITLE 2 SOLFATARICUS IN COMPLEX WITH ANTHRANILATE
COMPND MOL_ID: 1; COMPND 2 MOLECULE: ANTHRANILATE PHOSPHORIBOSYLTRANSFERASE; COMPND 3 CHAIN: A, B, C, D; COMPND 4 SYNONYM: TRPD; COMPND 5 EC: 2.4.2.18; COMPND 6 ENGINEERED: YES
SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SULFOLOBUS SOLFATARICUS; SOURCE 3 ORGANISM_TAXID: 2287; SOURCE 4 GENE: TRPD; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: W3110 TRPEA2; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PQE40
KEYWDS PROTEIN-LIGAND COMPLEX, TRANSFERASE
EXPDTA X-RAY DIFFRACTION
AUTHOR M.MARINO,M.DEUSS,R.STERNER,O.MAYANS
REVDAT 3 24-FEB-09 2GVQ 1 VERSN REVDAT 2 21-NOV-06 2GVQ 1 JRNL REVDAT 1 23-MAY-06 2GVQ 0
JRNL AUTH M.MARINO,M.DEUSS,D.I.SVERGUN,P.V.KONAREV,R.STERNER, JRNL AUTH 2 O.MAYANS JRNL TITL STRUCTURAL AND MUTATIONAL ANALYSIS OF SUBSTRATE JRNL TITL 2 COMPLEXATION BY ANTHRANILATE JRNL TITL 3 PHOSPHORIBOSYLTRANSFERASE FROM SULFOLOBUS JRNL TITL 4 SOLFATARICUS. JRNL REF J.BIOL.CHEM. V. 281 21410 2006 JRNL REFN ISSN 0021-9258 JRNL PMID 16714288 JRNL DOI 10.1074/JBC.M601403200
REMARK 1
REMARK 2 REMARK 2 RESOLUTION. 2.43 ANGSTROMS.
REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES, PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.43 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 49363 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.199 REMARK 3 FREE R VALUE : 0.242 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 584 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 10503 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 70 REMARK 3 SOLVENT ATOMS : 253 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 42.39 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.62900 REMARK 3 B22 (A**2) : 9.43200 REMARK 3 B33 (A**2) : -8.80400 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.46400 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.33 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : ANISOTROPIC REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4 REMARK 4 2GVQ COMPLIES WITH FORMAT V. 3.15, 01-DEC-08
REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 08-MAY-06. REMARK 100 THE RCSB ID CODE IS RCSB037606.
REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 11-DEC-02 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 6.00 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X06SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.951 REMARK 200 MONOCHROMATOR : SI (111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MAR REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 49363 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.430 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.9 REMARK 200 DATA REDUNDANCY : 3.840 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.06500 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 10.9900 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.43 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.50 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.2 REMARK 200 DATA REDUNDANCY IN SHELL : 3.41 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.43000 REMARK 200 <I/SIGMA(I)> FOR SHELL : 3.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: PDB ENTRY 1O17 REMARK 200 REMARK 200 REMARK: NULL
REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.80 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.40 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 1500, MES, PH 6.00, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 293K
REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL
REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA.
REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3080 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 25570 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -3.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3510 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 25280 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 4.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH D 610 LIES ON A SPECIAL POSITION.
REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 81 REMARK 465 GLY A 82 REMARK 465 ASP A 83 REMARK 465 SER A 344 REMARK 465 GLY A 345 REMARK 465 GLY B 81 REMARK 465 GLY B 82 REMARK 465 ASP B 83 REMARK 465 SER B 344 REMARK 465 GLY B 345 REMARK 465 THR C 80 REMARK 465 GLY C 81 REMARK 465 GLY C 82 REMARK 465 ASP C 83
REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 CD1 ILE C 67 CD1 ILE C 67 2657 2.12 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LEU B 97 CA - CB - CG ANGL. DEV. = 14.3 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 VAL A 71 62.73 -153.22 REMARK 500 ASN A 102 148.14 -172.91 REMARK 500 SER A 113 -124.21 -77.36 REMARK 500 LYS A 115 84.13 30.90 REMARK 500 HIS A 154 57.55 -140.16 REMARK 500 ASP A 223 48.93 -91.40 REMARK 500 ASN A 264 47.94 -142.04 REMARK 500 SER A 265 144.02 178.60 REMARK 500 LYS A 280 41.73 -104.80 REMARK 500 ASP A 281 79.91 174.62 REMARK 500 VAL B 71 66.96 -160.27 REMARK 500 ASN B 102 147.43 179.75 REMARK 500 SER B 113 -128.70 -99.58 REMARK 500 LYS B 115 69.14 38.57 REMARK 500 TYR B 206 -3.72 -59.71 REMARK 500 ASP B 223 44.37 -84.23 REMARK 500 ASP B 250 -8.25 -56.33 REMARK 500 PRO B 255 132.25 -39.93 REMARK 500 ASP B 281 74.48 -168.67 REMARK 500 ASN B 330 79.05 -179.19 REMARK 500 ASN C 2 77.55 71.84 REMARK 500 VAL C 71 62.21 -159.09 REMARK 500 LYS C 115 87.83 13.42 REMARK 500 ASP C 209 62.14 62.08 REMARK 500 LYS C 212 117.93 -163.22 REMARK 500 ASP C 223 44.58 -85.32 REMARK 500 ARG C 239 51.94 -110.56 REMARK 500 ASP C 281 88.35 -173.31 REMARK 500 ASP C 300 37.43 75.87 REMARK 500 SER C 344 -150.61 60.69 REMARK 500 VAL D 71 65.44 -158.76 REMARK 500 ASN D 89 74.88 -69.11 REMARK 500 ASN D 102 146.84 -173.02 REMARK 500 SER D 113 -118.07 -105.65 REMARK 500 THR D 171 -169.88 -129.67 REMARK 500 ASP D 209 49.63 86.66 REMARK 500 ASP D 223 36.76 -88.26 REMARK 500 PRO D 255 123.06 -34.59 REMARK 500 SER D 265 169.88 175.62 REMARK 500 ASP D 281 88.37 -157.52 REMARK 500 SER D 344 109.22 60.12 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: PLANAR GROUPS REMARK 500 REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS REMARK 500 AN RMSD GREATER THAN THIS VALUE REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI RMS TYPE REMARK 500 TYR A 152 0.07 SIDE_CHAIN REMARK 500 REMARK 500 REMARK: NULL
REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH C 519 DISTANCE = 5.07 ANGSTROMS REMARK 525 HOH B 427 DISTANCE = 5.11 ANGSTROMS REMARK 525 HOH C 531 DISTANCE = 5.52 ANGSTROMS REMARK 525 HOH D 645 DISTANCE = 6.77 ANGSTROMS REMARK 525 HOH A 390 DISTANCE = 5.07 ANGSTROMS REMARK 525 HOH B 446 DISTANCE = 7.02 ANGSTROMS REMARK 525 HOH C 548 DISTANCE = 5.81 ANGSTROMS REMARK 525 HOH B 450 DISTANCE = 5.42 ANGSTROMS REMARK 525 HOH D 653 DISTANCE = 5.97 ANGSTROMS REMARK 525 HOH A 398 DISTANCE = 5.46 ANGSTROMS REMARK 525 HOH B 454 DISTANCE = 5.48 ANGSTROMS REMARK 525 HOH C 562 DISTANCE = 7.61 ANGSTROMS REMARK 525 HOH A 410 DISTANCE = 5.89 ANGSTROMS
REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BE2 A 346 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BE2 B 401 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BE2 B 402 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BE2 C 501 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BE2 C 502 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BE2 D 601 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BE2 D 602
REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1O17 RELATED DB: PDB REMARK 900 APO FORM OF THE STRUCTURE REMARK 900 RELATED ID: 1GXB RELATED DB: PDB REMARK 900 ENZYME IN COMPLEX WITH PYROPHOSPHATE AND MAGNESIUM REMARK 900 RELATED ID: 1ZXY RELATED DB: PDB REMARK 900 ENZYME IN COMPLEX WITH PRPP AND MAGNESIUM REMARK 900 RELATED ID: 1ZYK RELATED DB: PDB REMARK 900 ENZYME IN COMPLEX WITH ANTHRANILATE, PRPP, MAGNESIUM
DBREF 2GVQ A 1 345 UNP P50384 TRPD_SULSO 1 345 DBREF 2GVQ B 1 345 UNP P50384 TRPD_SULSO 1 345 DBREF 2GVQ C 1 345 UNP P50384 TRPD_SULSO 1 345 DBREF 2GVQ D 1 345 UNP P50384 TRPD_SULSO 1 345
SEQRES 1 A 345 MET ASN ILE ASN GLU ILE LEU LYS LYS LEU ILE ASN LYS SEQRES 2 A 345 SER ASP LEU GLU ILE ASN GLU ALA GLU GLU LEU ALA LYS SEQRES 3 A 345 ALA ILE ILE ARG GLY GLU VAL PRO GLU ILE LEU VAL SER SEQRES 4 A 345 ALA ILE LEU VAL ALA LEU ARG MET LYS GLY GLU SER LYS SEQRES 5 A 345 ASN GLU ILE VAL GLY PHE ALA ARG ALA MET ARG GLU LEU SEQRES 6 A 345 ALA ILE LYS ILE ASP VAL PRO ASN ALA ILE ASP THR ALA SEQRES 7 A 345 GLY THR GLY GLY ASP GLY LEU GLY THR VAL ASN VAL SER SEQRES 8 A 345 THR ALA SER ALA ILE LEU LEU SER LEU VAL ASN PRO VAL SEQRES 9 A 345 ALA LYS HIS GLY ASN ARG ALA VAL SER GLY LYS SER GLY SEQRES 10 A 345 SER ALA ASP VAL LEU GLU ALA LEU GLY TYR ASN ILE ILE SEQRES 11 A 345 VAL PRO PRO GLU ARG ALA LYS GLU LEU VAL ASN LYS THR SEQRES 12 A 345 ASN PHE VAL PHE LEU PHE ALA GLN TYR TYR HIS PRO ALA SEQRES 13 A 345 MET LYS ASN VAL ALA ASN VAL ARG LYS THR LEU GLY ILE SEQRES 14 A 345 ARG THR ILE PHE ASN ILE LEU GLY PRO LEU THR ASN PRO SEQRES 15 A 345 ALA ASN ALA LYS TYR GLN LEU MET GLY VAL PHE SER LYS SEQRES 16 A 345 ASP HIS LEU ASP LEU LEU SER LYS SER ALA TYR GLU LEU SEQRES 17 A 345 ASP PHE ASN LYS ILE ILE LEU VAL TYR GLY GLU PRO GLY SEQRES 18 A 345 ILE ASP GLU VAL SER PRO ILE GLY ASN THR PHE MET LYS SEQRES 19 A 345 ILE VAL SER LYS ARG GLY ILE GLU GLU VAL LYS LEU ASN SEQRES 20 A 345 VAL THR ASP PHE GLY ILE SER PRO ILE PRO ILE GLU LYS SEQRES 21 A 345 LEU ILE VAL ASN SER ALA GLU ASP SER ALA ILE LYS ILE SEQRES 22 A 345 VAL ARG ALA PHE LEU GLY LYS ASP GLU HIS VAL ALA GLU SEQRES 23 A 345 PHE ILE LYS ILE ASN THR ALA VAL ALA LEU PHE ALA LEU SEQRES 24 A 345 ASP ARG VAL GLY ASP PHE ARG GLU GLY TYR GLU TYR ALA SEQRES 25 A 345 ASP HIS LEU ILE GLU LYS SER LEU ASP LYS LEU ASN GLU SEQRES 26 A 345 ILE ILE SER MET ASN GLY ASP VAL THR LYS LEU LYS THR SEQRES 27 A 345 ILE VAL VAL LYS SER SER GLY SEQRES 1 B 345 MET ASN ILE ASN GLU ILE LEU LYS LYS LEU ILE ASN LYS SEQRES 2 B 345 SER ASP LEU GLU ILE ASN GLU ALA GLU GLU LEU ALA LYS SEQRES 3 B 345 ALA ILE ILE ARG GLY GLU VAL PRO GLU ILE LEU VAL SER SEQRES 4 B 345 ALA ILE LEU VAL ALA LEU ARG MET LYS GLY GLU SER LYS SEQRES 5 B 345 ASN GLU ILE VAL GLY PHE ALA ARG ALA MET ARG GLU LEU SEQRES 6 B 345 ALA ILE LYS ILE ASP VAL PRO ASN ALA ILE ASP THR ALA SEQRES 7 B 345 GLY THR GLY GLY ASP GLY LEU GLY THR VAL ASN VAL SER SEQRES 8 B 345 THR ALA SER ALA ILE LEU LEU SER LEU VAL ASN PRO VAL SEQRES 9 B 345 ALA LYS HIS GLY ASN ARG ALA VAL SER GLY LYS SER GLY SEQRES 10 B 345 SER ALA ASP VAL LEU GLU ALA LEU GLY TYR ASN ILE ILE SEQRES 11 B 345 VAL PRO PRO GLU ARG ALA LYS GLU LEU VAL ASN LYS THR SEQRES 12 B 345 ASN PHE VAL PHE LEU PHE ALA GLN TYR TYR HIS PRO ALA SEQRES 13 B 345 MET LYS ASN VAL ALA ASN VAL ARG LYS THR LEU GLY ILE SEQRES 14 B 345 ARG THR ILE PHE ASN ILE LEU GLY PRO LEU THR ASN PRO SEQRES 15 B 345 ALA ASN ALA LYS TYR GLN LEU MET GLY VAL PHE SER LYS SEQRES 16 B 345 ASP HIS LEU ASP LEU LEU SER LYS SER ALA TYR GLU LEU SEQRES 17 B 345 ASP PHE ASN LYS ILE ILE LEU VAL TYR GLY GLU PRO GLY SEQRES 18 B 345 ILE ASP GLU VAL SER PRO ILE GLY ASN THR PHE MET LYS SEQRES 19 B 345 ILE VAL SER LYS ARG GLY ILE GLU GLU VAL LYS LEU ASN SEQRES 20 B 345 VAL THR ASP PHE GLY ILE SER PRO ILE PRO ILE GLU LYS SEQRES 21 B 345 LEU ILE VAL ASN SER ALA GLU ASP SER ALA ILE LYS ILE SEQRES 22 B 345 VAL ARG ALA PHE LEU GLY LYS ASP GLU HIS VAL ALA GLU SEQRES 23 B 345 PHE ILE LYS ILE ASN THR ALA VAL ALA LEU PHE ALA LEU SEQRES 24 B 345 ASP ARG VAL GLY ASP PHE ARG GLU GLY TYR GLU TYR ALA SEQRES 25 B 345 ASP HIS LEU ILE GLU LYS SER LEU ASP LYS LEU ASN GLU SEQRES 26 B 345 ILE ILE SER MET ASN GLY ASP VAL THR LYS LEU LYS THR SEQRES 27 B 345 ILE VAL VAL LYS SER SER GLY SEQRES 1 C 345 MET ASN ILE ASN GLU ILE LEU LYS LYS LEU ILE ASN LYS SEQRES 2 C 345 SER ASP LEU GLU ILE ASN GLU ALA GLU GLU LEU ALA LYS SEQRES 3 C 345 ALA ILE ILE ARG GLY GLU VAL PRO GLU ILE LEU VAL SER SEQRES 4 C 345 ALA ILE LEU VAL ALA LEU ARG MET LYS GLY GLU SER LYS SEQRES 5 C 345 ASN GLU ILE VAL GLY PHE ALA ARG ALA MET ARG GLU LEU SEQRES 6 C 345 ALA ILE LYS ILE ASP VAL PRO ASN ALA ILE ASP THR ALA SEQRES 7 C 345 GLY THR GLY GLY ASP GLY LEU GLY THR VAL ASN VAL SER SEQRES 8 C 345 THR ALA SER ALA ILE LEU LEU SER LEU VAL ASN PRO VAL SEQRES 9 C 345 ALA LYS HIS GLY ASN ARG ALA VAL SER GLY LYS SER GLY SEQRES 10 C 345 SER ALA ASP VAL LEU GLU ALA LEU GLY TYR ASN ILE ILE SEQRES 11 C 345 VAL PRO PRO GLU ARG ALA LYS GLU LEU VAL ASN LYS THR SEQRES 12 C 345 ASN PHE VAL PHE LEU PHE ALA GLN TYR TYR HIS PRO ALA SEQRES 13 C 345 MET LYS ASN VAL ALA ASN VAL ARG LYS THR LEU GLY ILE SEQRES 14 C 345 ARG THR ILE PHE ASN ILE LEU GLY PRO LEU THR ASN PRO SEQRES 15 C 345 ALA ASN ALA LYS TYR GLN LEU MET GLY VAL PHE SER LYS SEQRES 16 C 345 ASP HIS LEU ASP LEU LEU SER LYS SER ALA TYR GLU LEU SEQRES 17 C 345 ASP PHE ASN LYS ILE ILE LEU VAL TYR GLY GLU PRO GLY SEQRES 18 C 345 ILE ASP GLU VAL SER PRO ILE GLY ASN THR PHE MET LYS SEQRES 19 C 345 ILE VAL SER LYS ARG GLY ILE GLU GLU VAL LYS LEU ASN SEQRES 20 C 345 VAL THR ASP PHE GLY ILE SER PRO ILE PRO ILE GLU LYS SEQRES 21 C 345 LEU ILE VAL ASN SER ALA GLU ASP SER ALA ILE LYS ILE SEQRES 22 C 345 VAL ARG ALA PHE LEU GLY LYS ASP GLU HIS VAL ALA GLU SEQRES 23 C 345 PHE ILE LYS ILE ASN THR ALA VAL ALA LEU PHE ALA LEU SEQRES 24 C 345 ASP ARG VAL GLY ASP PHE ARG GLU GLY TYR GLU TYR ALA SEQRES 25 C 345 ASP HIS LEU ILE GLU LYS SER LEU ASP LYS LEU ASN GLU SEQRES 26 C 345 ILE ILE SER MET ASN GLY ASP VAL THR LYS LEU LYS THR SEQRES 27 C 345 ILE VAL VAL LYS SER SER GLY SEQRES 1 D 345 MET ASN ILE ASN GLU ILE LEU LYS LYS LEU ILE ASN LYS SEQRES 2 D 345 SER ASP LEU GLU ILE ASN GLU ALA GLU GLU LEU ALA LYS SEQRES 3 D 345 ALA ILE ILE ARG GLY GLU VAL PRO GLU ILE LEU VAL SER SEQRES 4 D 345 ALA ILE LEU VAL ALA LEU ARG MET LYS GLY GLU SER LYS SEQRES 5 D 345 ASN GLU ILE VAL GLY PHE ALA ARG ALA MET ARG GLU LEU SEQRES 6 D 345 ALA ILE LYS ILE ASP VAL PRO ASN ALA ILE ASP THR ALA SEQRES 7 D 345 GLY THR GLY GLY ASP GLY LEU GLY THR VAL ASN VAL SER SEQRES 8 D 345 THR ALA SER ALA ILE LEU LEU SER LEU VAL ASN PRO VAL SEQRES 9 D 345 ALA LYS HIS GLY ASN ARG ALA VAL SER GLY LYS SER GLY SEQRES 10 D 345 SER ALA ASP VAL LEU GLU ALA LEU GLY TYR ASN ILE ILE SEQRES 11 D 345 VAL PRO PRO GLU ARG ALA LYS GLU LEU VAL ASN LYS THR SEQRES 12 D 345 ASN PHE VAL PHE LEU PHE ALA GLN TYR TYR HIS PRO ALA SEQRES 13 D 345 MET LYS ASN VAL ALA ASN VAL ARG LYS THR LEU GLY ILE SEQRES 14 D 345 ARG THR ILE PHE ASN ILE LEU GLY PRO LEU THR ASN PRO SEQRES 15 D 345 ALA ASN ALA LYS TYR GLN LEU MET GLY VAL PHE SER LYS SEQRES 16 D 345 ASP HIS LEU ASP LEU LEU SER LYS SER ALA TYR GLU LEU SEQRES 17 D 345 ASP PHE ASN LYS ILE ILE LEU VAL TYR GLY GLU PRO GLY SEQRES 18 D 345 ILE ASP GLU VAL SER PRO ILE GLY ASN THR PHE MET LYS SEQRES 19 D 345 ILE VAL SER LYS ARG GLY ILE GLU GLU VAL LYS LEU ASN SEQRES 20 D 345 VAL THR ASP PHE GLY ILE SER PRO ILE PRO ILE GLU LYS SEQRES 21 D 345 LEU ILE VAL ASN SER ALA GLU ASP SER ALA ILE LYS ILE SEQRES 22 D 345 VAL ARG ALA PHE LEU GLY LYS ASP GLU HIS VAL ALA GLU SEQRES 23 D 345 PHE ILE LYS ILE ASN THR ALA VAL ALA LEU PHE ALA LEU SEQRES 24 D 345 ASP ARG VAL GLY ASP PHE ARG GLU GLY TYR GLU TYR ALA SEQRES 25 D 345 ASP HIS LEU ILE GLU LYS SER LEU ASP LYS LEU ASN GLU SEQRES 26 D 345 ILE ILE SER MET ASN GLY ASP VAL THR LYS LEU LYS THR SEQRES 27 D 345 ILE VAL VAL LYS SER SER GLY
HET BE2 A 346 10 HET BE2 B 401 10 HET BE2 B 402 10 HET BE2 C 501 10 HET BE2 C 502 10 HET BE2 D 601 10 HET BE2 D 602 10
HETNAM BE2 2-AMINOBENZOIC ACID
FORMUL 5 BE2 7(C7 H7 N O2) FORMUL 12 HOH *253(H2 O)
HELIX 1 1 ASN A 2 ASN A 12 1 11 HELIX 2 2 GLU A 17 ARG A 30 1 14 HELIX 3 3 PRO A 34 GLY A 49 1 16 HELIX 4 4 SER A 51 ALA A 66 1 16 HELIX 5 5 ASN A 89 SER A 99 1 11 HELIX 6 6 GLY A 117 GLY A 126 1 10 HELIX 7 7 PRO A 132 ASN A 144 1 13 HELIX 8 8 ALA A 150 HIS A 154 1 5 HELIX 9 9 PRO A 155 ASN A 159 5 5 HELIX 10 10 VAL A 160 GLY A 168 1 9 HELIX 11 11 THR A 171 THR A 180 5 10 HELIX 12 12 SER A 194 GLU A 207 1 14 HELIX 13 13 THR A 249 GLY A 252 5 4 HELIX 14 14 PRO A 257 LEU A 261 5 5 HELIX 15 15 SER A 265 LEU A 278 1 14 HELIX 16 16 ASP A 281 LEU A 299 1 19 HELIX 17 17 ASP A 304 GLU A 317 1 14 HELIX 18 18 LYS A 318 ASN A 330 1 13 HELIX 19 19 ASP A 332 LYS A 342 1 11 HELIX 20 20 ASN B 2 ASN B 12 1 11 HELIX 21 21 GLU B 17 GLY B 31 1 15 HELIX 22 22 PRO B 34 GLY B 49 1 16 HELIX 23 23 SER B 51 ALA B 66 1 16 HELIX 24 24 ASN B 89 LEU B 100 1 12 HELIX 25 25 GLY B 117 GLY B 126 1 10 HELIX 26 26 PRO B 132 THR B 143 1 12 HELIX 27 27 ALA B 150 HIS B 154 1 5 HELIX 28 28 PRO B 155 ASN B 159 5 5 HELIX 29 29 VAL B 160 GLY B 168 1 9 HELIX 30 30 THR B 171 THR B 180 5 10 HELIX 31 31 LYS B 195 TYR B 206 1 12 HELIX 32 32 THR B 249 GLY B 252 5 4 HELIX 33 33 PRO B 257 LEU B 261 5 5 HELIX 34 34 SER B 265 LEU B 278 1 14 HELIX 35 35 ASP B 281 LEU B 299 1 19 HELIX 36 36 ASP B 304 MET B 329 1 26 HELIX 37 37 THR B 334 VAL B 340 1 7 HELIX 38 38 ASN C 2 ASN C 12 1 11 HELIX 39 39 GLU C 17 ARG C 30 1 14 HELIX 40 40 PRO C 34 GLY C 49 1 16 HELIX 41 41 SER C 51 ALA C 66 1 16 HELIX 42 42 ASN C 89 LEU C 100 1 12 HELIX 43 43 GLY C 117 GLY C 126 1 10 HELIX 44 44 PRO C 132 ASN C 144 1 13 HELIX 45 45 ALA C 150 HIS C 154 1 5 HELIX 46 46 PRO C 155 ASN C 159 5 5 HELIX 47 47 VAL C 160 GLY C 168 1 9 HELIX 48 48 THR C 171 THR C 180 5 10 HELIX 49 49 SER C 194 GLU C 207 1 14 HELIX 50 50 THR C 249 GLY C 252 5 4 HELIX 51 51 PRO C 257 ILE C 262 5 6 HELIX 52 52 SER C 265 GLY C 279 1 15 HELIX 53 53 ASP C 281 ASP C 300 1 20 HELIX 54 54 ASP C 304 ILE C 316 1 13 HELIX 55 55 LYS C 318 ASN C 330 1 13 HELIX 56 56 ASP C 332 SER C 343 1 12 HELIX 57 57 ASN D 2 ASN D 12 1 11 HELIX 58 58 GLU D 17 ARG D 30 1 14 HELIX 59 59 PRO D 34 GLY D 49 1 16 HELIX 60 60 SER D 51 ALA D 66 1 16 HELIX 61 61 ASN D 89 SER D 99 1 11 HELIX 62 62 GLY D 117 LEU D 125 1 9 HELIX 63 63 PRO D 132 ASN D 144 1 13 HELIX 64 64 ALA D 150 HIS D 154 1 5 HELIX 65 65 MET D 157 GLY D 168 1 12 HELIX 66 66 THR D 171 THR D 180 5 10 HELIX 67 67 SER D 194 GLU D 207 1 14 HELIX 68 68 ASN D 247 GLY D 252 5 6 HELIX 69 69 PRO D 257 ILE D 262 1 6 HELIX 70 70 SER D 265 LEU D 278 1 14 HELIX 71 71 ASP D 281 LEU D 299 1 19 HELIX 72 72 ASP D 304 ASN D 330 1 27 HELIX 73 73 ASP D 332 SER D 343 1 12
SHEET 1 A 5 ILE A 75 ASP A 76 0 SHEET 2 A 5 TYR A 187 GLY A 191 1 O LEU A 189 N ASP A 76 SHEET 3 A 5 LYS A 212 GLY A 218 1 O ILE A 214 N MET A 190 SHEET 4 A 5 ASN A 230 SER A 237 -1 O VAL A 236 N ILE A 213 SHEET 5 A 5 GLY A 240 ASN A 247 -1 O GLU A 242 N ILE A 235 SHEET 1 B 2 VAL A 104 GLY A 108 0 SHEET 2 B 2 PHE A 145 PHE A 149 1 O LEU A 148 N LYS A 106 SHEET 1 C 5 ILE B 75 ASP B 76 0 SHEET 2 C 5 TYR B 187 GLY B 191 1 O LEU B 189 N ASP B 76 SHEET 3 C 5 LYS B 212 GLY B 218 1 O ILE B 214 N MET B 190 SHEET 4 C 5 ASN B 230 SER B 237 -1 O PHE B 232 N TYR B 217 SHEET 5 C 5 GLY B 240 ASN B 247 -1 O GLY B 240 N SER B 237 SHEET 1 D 2 VAL B 104 GLY B 108 0 SHEET 2 D 2 PHE B 145 PHE B 149 1 O LEU B 148 N LYS B 106 SHEET 1 E 5 ILE C 75 ALA C 78 0 SHEET 2 E 5 TYR C 187 GLY C 191 1 O TYR C 187 N ASP C 76 SHEET 3 E 5 LYS C 212 GLY C 218 1 O ILE C 214 N MET C 190 SHEET 4 E 5 ASN C 230 SER C 237 -1 O PHE C 232 N TYR C 217 SHEET 5 E 5 GLY C 240 ASN C 247 -1 O LEU C 246 N THR C 231 SHEET 1 F 2 VAL C 104 GLY C 108 0 SHEET 2 F 2 PHE C 145 PHE C 149 1 O LEU C 148 N LYS C 106 SHEET 1 G 5 ILE D 75 ASP D 76 0 SHEET 2 G 5 TYR D 187 GLY D 191 1 O LEU D 189 N ASP D 76 SHEET 3 G 5 LYS D 212 GLY D 218 1 O ILE D 214 N GLN D 188 SHEET 4 G 5 THR D 231 SER D 237 -1 O LYS D 234 N LEU D 215 SHEET 5 G 5 GLY D 240 VAL D 244 -1 O VAL D 244 N MET D 233 SHEET 1 H 2 VAL D 104 GLY D 108 0 SHEET 2 H 2 PHE D 145 PHE D 149 1 O LEU D 148 N LYS D 106
CISPEP 1 GLU A 219 PRO A 220 0 0.33 CISPEP 2 GLU B 219 PRO B 220 0 0.46 CISPEP 3 GLU C 219 PRO C 220 0 0.18
SITE 1 AC1 6 ASN A 109 ALA A 150 GLN A 151 HIS A 154 SITE 2 AC1 6 ARG A 164 GLY A 177 SITE 1 AC2 7 ASN B 109 GLN B 151 HIS B 154 MET B 157 SITE 2 AC2 7 ARG B 164 PHE B 173 BE2 B 402 SITE 1 AC3 8 GLY B 79 THR B 80 HIS B 107 ASN B 109 SITE 2 AC3 8 ALA B 150 GLY B 177 PRO B 178 BE2 B 401 SITE 1 AC4 4 HIS C 107 ASN C 109 GLY C 177 BE2 C 502 SITE 1 AC5 5 ASN C 109 HIS C 154 MET C 157 ARG C 164 SITE 2 AC5 5 BE2 C 501 SITE 1 AC6 7 GLY D 79 THR D 80 HIS D 107 ASN D 109 SITE 2 AC6 7 GLY D 177 PRO D 178 BE2 D 602 SITE 1 AC7 7 ASN D 109 ALA D 150 GLN D 151 HIS D 154 SITE 2 AC7 7 MET D 157 ARG D 164 BE2 D 601
CRYST1 91.814 65.621 115.607 90.00 107.39 90.00 P 1 2 1 8
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.010892 0.000000 0.003411 0.00000
SCALE2 0.000000 0.015239 0.000000 0.00000
SCALE3 0.000000 0.000000 0.009064 0.00000